MetaCap

Elanco Animal Health Earnings

NYSE: ELANHealth CareBiotechnology: Pharmaceutical PreparationsUSD

22.92+0.38 (+1.69%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Fri, Nov 6, 2026

Before market open

Fiscal period

Sep/2026

EPS estimate

$0.20

Elanco Animal Health earnings summary

Elanco Animal Health is scheduled to report Sep/2026 earnings on Nov 6, 2026 before the market opens, with analysts expecting EPS of $0.20. In its most recent report on Aug 5, 2026 (Q2 2026), ELAN posted EPS of $0.11. Revenue for the quarter was $1.37 billion.

Quarterly EPS is up 450.0% from the same quarter a year earlier. Across the last 16 reports, ELAN shares moved an average of 6.8% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

ELAN earnings history

Elanco Animal Health reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 5, 2026—$0.11—+7.0%
May 6, 2026—$0.11—-16.0%
Feb 24, 2026—$-0.55—-11.5%
Nov 5, 2025—$-0.07—-1.9%
Aug 7, 2025—$0.02—+7.7%
May 7, 2025—$0.13—+8.0%
Feb 25, 2025—$-0.01—-0.3%
Nov 7, 2024—$0.73—-0.6%
Aug 8, 2024—$-0.10—+11.1%
May 8, 2024—$0.06—+1.1%
Feb 26, 2024—$-0.29—+2.6%
Nov 7, 2023—$-2.22—+10.7%
Aug 7, 2023—$-0.20—-4.5%
May 9, 2023—$0.21—-0.7%
Mar 1, 2023—$-0.11—-13.8%
Nov 8, 2022—$-0.13—-11.8%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related